ARS Pharmaceuticals Inc. stock rose Friday as FDA identified deficiencies in rival Aquestive's application, delaying ...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On ...

Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives ...

Shares in ARS Pharmaceuticals were in freefall in pre-market trading this morning as it emerged that the FDA had declined to approve its application for its lead product, aiming to become the first ...

New guidelines help non-medics correctly identify acute allergic reactions requiring epinephrine administration ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.

Please provide your email address to receive an email when new articles are posted on . Researchers captured patient and caregiver expected anxiety and well-being with different epinephrine treatment ...

Several universities across the country keep undesignated stock epinephrine in their dining halls, providing a critical medication for students facing severe allergic reactions to food. The University ...

An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...

ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...

If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...